TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
AdaptHealth ( (AHCO) ) has shared an announcement.
On August 5, 2025, AdaptHealth Corp. announced a new five-year capitated partnership with a major national healthcare system, making it the exclusive provider of home medical equipment and supplies for over 10 million members. This agreement, covering Medicare Advantage, Medicaid Managed Care, and privately insured patients, positions AdaptHealth to drive non-acquired growth and transform healthcare services at home by delivering consistent experiences and predictable costs.
The most recent analyst rating on (AHCO) stock is a Buy with a $11.00 price target. To see the full list of analyst forecasts on AdaptHealth stock, see the AHCO Stock Forecast page.
Spark’s Take on AHCO Stock
According to Spark, TipRanks’ AI Analyst, AHCO is a Neutral.
AdaptHealth’s overall score reflects a stable financial position with positive trends in profitability and cash flow, tempered by revenue challenges and sector-specific hurdles. The valuation is reasonable, with technical analysis indicating a neutral trend, and earnings call insights suggesting cautious optimism amid mixed results.
To see Spark’s full report on AHCO stock, click here.
More about AdaptHealth
AdaptHealth Corp. is a national leader in providing patient-centered, healthcare-at-home solutions, including home medical equipment, medical supplies, and related services. The company operates across four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home, serving approximately 4.2 million patients annually in all 50 states through a network of about 630 locations.
Average Trading Volume: 1,321,559
Technical Sentiment Signal: Sell
Current Market Cap: $1.18B
Find detailed analytics on AHCO stock on TipRanks’ Stock Analysis page.